In addition, the immunophenotyping results of breast tumor tissues before treatment showed that TNBC and HER2+ breast cancer were mainly immune-infiltrated phenotype, and luminal breast cancer was mainly immune-desert phenotype and immune-excluded phenotype (Fig. 3E). This evidence concerns the gene ERBB2 and breast carcinoma.